Tendinopathy: When to Seek a Second Opinion

What Is Tendinopathy and Why Does It Persist?

Tendinopathy is a failed-healing response inside a tendon, not a straightforward inflammatory condition. The classic histological picture shows disorganized collagen, increased ground substance, and neovascularization without the cellular infiltrate typical of acute tendinitis. Maffulli et al. Coined the term "tendinopathy" specifically to separate this degenerative picture from acute inflammation.

The Sites That Matter Most

The five most clinically significant locations are:

• Achilles tendon (mid-portion and insertional subtypes behave differently)
• Patellar tendon (jumper's knee)
• Rotator cuff tendons (supraspinatus most common)
• Lateral epicondyle (tennis elbow, formally common extensor tendinopathy)
• Proximal hamstring at the ischial tuberosity

Each site has a distinct biomechanical load profile, which affects both exercise prescription and injection targeting.

Why Tendons Heal Slowly

Tendons are hypovascular. Oxygen tension inside the mid-portion of the Achilles can be lower than in cartilage. A 2010 review in the Journal of Orthopaedic Research confirmed that intratendinous oxygen partial pressure is roughly 7 to 12 mmHg, which slows fibroblast metabolism and collagen turnover. That biology is the main reason tendinopathy timelines are measured in months, not weeks.

Patients often present after weeks of rest that provided temporary pain relief but no structural change. Returning to full activity then reproduces symptoms. This cycle, pain with load, rest, brief relief, re-injury, is the defining natural history and a sign that passive treatment alone will not work.

First-Line Management: Load Is the Medicine

Structured progressive loading is the best-validated treatment for tendinopathy. The goal is to apply controlled mechanical stress that stimulates collagen synthesis and reorganization without exceeding the tendon's current capacity.

Eccentric Exercise

The Alfredson protocol for Achilles tendinopathy, published in 1998, remains one of the most replicated findings in musculoskeletal medicine. Alfredson et al. (N=15 athletes) reported that 12 weeks of heavy-load eccentric calf training produced full return to activity in all subjects, where previous conservative care had failed in each case. The protocol calls for three sets of 15 repetitions twice daily, progressing to added weight when body weight alone becomes pain-free.

Eccentric training has since been applied to patellar tendinopathy using the decline squat variant. A randomized controlled trial by Jonsson and Alfredson (N=17) found the decline eccentric squat superior to a standard squat at 12 weeks for Victorian Institute of Sport Assessment (VISA) scores.

Heavy Slow Resistance Training

Some patients cannot tolerate the eccentric-only format, particularly those with insertional Achilles tendinopathy where compressive loads at end-range dorsiflexion aggravate symptoms. Heavy slow resistance (HSR) training, using full concentric-eccentric cycles at high loads and slow tempo, produces comparable outcomes. Beyer et al. (N=58, RCT) found HSR non-inferior to Alfredson eccentric training at 12 months, with better patient satisfaction and compliance.

How Long to Persist Before Escalating

The 2019 British Journal of Sports Medicine load-management consensus states that clinicians should allow at least 12 weeks of supervised loading before declaring treatment failure. That consensus document, authored by Cook, Docking, and colleagues, also notes that imaging findings alone should not drive clinical decisions, because tendon structural changes on ultrasound or MRI correlate poorly with pain or function in chronic cases.

Three months with a trained physiotherapist, not three months of self-directed home exercises that may be performed incorrectly, is the standard before escalation.

When Conservative Care Is Not Enough: Specific Triggers for a Second Opinion

"Not getting better" is too vague a standard. Specific, concrete triggers indicate that your current provider's approach needs review.

Trigger 1: No Functional Improvement After 12 Weeks of Supervised Loading

Pain scores and VISA scores (for Achilles or patellar) should show a measurable trend by week 8 to 12. A VISA-A score below 50 at 12 weeks after supervised eccentric training signals poor trajectory. The VISA-A questionnaire was validated by Robinson et al. And has a minimal clinically important difference of approximately 6 to 8 points.

If your provider has not used a validated outcome measure, that itself is worth noting when you see a second opinion. Tracking with numbers, not just verbal check-ins, is standard of care.

Trigger 2: Three or More Corticosteroid Injections

Corticosteroids reduce pain short-term but do not address the underlying degenerative pathology. A landmark Lancet RCT by Coombes et al. (N=165) showed that a single corticosteroid injection for lateral epicondylalgia provided relief at 4 weeks but produced significantly worse outcomes than placebo or physiotherapy at 1 year, with a recurrence rate of 72% vs. 8% for physiotherapy. Repeated injections compound this by weakening collagen structure and raising the risk of tendon rupture.

Three injections at the same site without sustained benefit is a ceiling. Continuing that approach lacks evidence and adds biological risk.

Trigger 3: Imaging Showing Structural Compromise

A partial-thickness or full-thickness tear changes the management equation entirely. MRI grading of rotator cuff tears and patellar tendon tears directly influences surgical decision-making. Hodgson et al. In the BMJ noted that surgical repair of full-thickness supraspinatus tears produces better functional outcomes than physiotherapy alone in active patients under 65.

If imaging has never been ordered after three or more months of failed treatment, requesting it is reasonable. Ultrasound is cost-effective for Achilles and patellar tendons. MRI is preferred for rotator cuff and proximal hamstring.

Trigger 4: Symptoms That Suggest a Different Diagnosis

Several serious conditions mimic tendinopathy:

• Stress fracture at the calcaneal apophysis or tibial cortex
• Referred pain from lumbar or cervical radiculopathy mimicking hamstring or supraspinatus symptoms
• Xanthoma in patients with familial hypercholesterolemia, which deposits within Achilles tendons
• Systemic inflammatory arthropathy (psoriatic arthritis, ankylosing spondylitis) causing enthesopathy that looks like insertional tendinopathy

NICE guidelines on spondyloarthritis (NG65) specifically identify recurrent enthesitis as a diagnostic criterion, and a rheumatology referral is appropriate when bilateral or multi-site tendinopathy arises without a clear mechanical explanation.

Injection Therapies Beyond Corticosteroids

When loading programs have plateaued and corticosteroids have been exhausted or are contraindicated, three injection options have meaningful evidence.

Platelet-Rich Plasma (PRP)

PRP concentrates growth factors from autologous blood, including platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta), that may stimulate tenocyte activity. Evidence quality is improving.

A 2021 BMJ systematic review and meta-analysis by Chen et al. (21 RCTs, N=1,408) found that leukocyte-rich PRP produced statistically significant improvements in pain and function for lateral epicondylalgia and Achilles tendinopathy compared to placebo at 3 and 6 months, with a standardized mean difference of 0.84 (95% CI 0.45 to 1.23, P<0.001). The authors noted high heterogeneity in PRP preparation protocols, which remains the field's main limitation.

If a provider offers PRP, ask specifically whether they use leukocyte-rich or leukocyte-poor preparations and how many platelets per microliter the product reaches. Preparations below 1 million platelets/mcL are unlikely to deliver a therapeutic dose.

High-Volume Injection (HVI)

High-volume injection uses 40 to 50 mL of normal saline, sometimes with a small corticosteroid component, to mechanically disrupt neovascularization at the ventral Achilles surface under ultrasound guidance. A Cochrane-registered RCT by Humphrey et al. (N=28) found that HVI produced greater VISA-A improvement than sham injection at 6 weeks, though longer follow-up data are limited.

Sclerosing Injections (Polidocanol)

Polidocanol sclerotherapy targets the neovessels that accompany sensory nerve fibers in tendinopathy. Alfredson and Ohberg (N=20) reported a 45% reduction in visual analogue scale pain scores at 12 months in Achilles tendinopathy patients treated with ultrasound-guided polidocanol. This approach requires an interventional musculoskeletal radiologist or sports medicine physician experienced in color Doppler-guided injection.

BPC-157: Off-Label Peptide Use in Refractory Tendinopathy

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a gastric mucosal protein. In rodent models, it has shown accelerated tendon-to-bone healing, upregulation of VEGF-receptor expression, and reduced inflammatory cytokine profiles. Pevec et al. Demonstrated accelerated Achilles tendon healing in rats with BPC-157 compared to saline control across histological and mechanical testing endpoints.

What the Preclinical Data Show

Animal models across multiple labs have shown:

• Faster collagen fiber alignment after transection injury
• Reduced expression of inflammatory markers at 7 and 14 days post-injury
• Improved tendon-to-bone pullout strength at 21 days in rotator cuff repair models

What Is Missing

No Phase II or Phase III human randomized controlled trial for BPC-157 in tendinopathy has been completed as of mid-2025. The FDA has not approved BPC-157 for any indication. It is not available as a prescription drug in the United States. Compounded BPC-157 for injection falls under the jurisdiction of state pharmacy boards and FDA oversight of compounding pharmacies.

A clinical framework for considering BPC-157 in refractory tendinopathy would require: confirmed tendinopathy diagnosis on imaging, failure of at least 12 weeks of supervised loading, failure of at least one evidence-based injection, absence of a surgical indication, and a fully informed consent discussion covering the lack of human clinical trial data.

Patients requesting BPC-157 should seek providers who can explain the preclinical basis, acknowledge the data gap, and monitor outcomes with validated scores rather than anecdotal reports.

Surgical Referral: Clear Indications

Surgery is not a second opinion. It is a distinct escalation step with its own indications and risks. The threshold for referral differs by tendon site.

Achilles Tendon

Acute complete rupture is a surgical emergency in active patients. A Cochrane review by Khan et al. Comparing operative vs. Non-operative management of acute Achilles rupture found re-rupture rates of 3.5% vs. 12.6% favoring surgery, but wound complication rates of 4.7% vs. 0% favoring conservative care. The decision requires shared discussion with an orthopedic surgeon within days of injury.

Chronic mid-portion tendinopathy without rupture rarely requires surgery as a first step, and surgery should follow documented failure of at least two conservative modalities.

Rotator Cuff

Full-thickness tears in patients under 65 with mechanical symptoms and no response to 6 months of physiotherapy meet standard referral criteria. Partial-thickness tears with greater than 50% cross-sectional involvement on MRI also warrant orthopedic evaluation.

Patellar Tendon

Open or arthroscopic debridement of the patellar tendon is reserved for patients with confirmed hypoechoic nodules on ultrasound, VISA-P scores below 35 after 6 months of loading, and failed PRP or sclerosing therapy.

Building a Second-Opinion Appointment That Produces Actionable Results

Walking into a second-opinion visit unprepared produces a restarted workup, not a new plan. Bring the following:

1. All imaging reports and images on disc or digital transfer (MRI and ultrasound)
2. A written log of every treatment tried, with approximate dates, doses, and outcome
3. Your current VISA score (calculate it online before the appointment)
4. A list of all injections with dates and approximate response duration
5. Your activity history and specific functional goals

A sports medicine physician with a Certificate of Added Qualification (CAQ), a physiatrist, or an orthopedic surgeon with a sports medicine subspecialty are all appropriate second-opinion sources depending on the clinical question.

The American College of Sports Medicine position statement on musculoskeletal injury management recommends a multidisciplinary approach for refractory tendinopathy, specifically naming physiotherapy, pain specialists, and surgical consultation as components of a stepped-care pathway.

Summary of the Evidence-Based Step-Care Pathway

| Step | Intervention | Minimum Duration | Trigger to Advance | |------|-------------|-----------------|-------------------| | 1 | Supervised progressive loading (eccentric or HSR) | 12 weeks | VISA improvement <6 points or continued functional limitation | | 2 | PRP injection plus continued loading | 8 to 12 weeks post-injection | No meaningful improvement on VISA | | 3 | HVI or sclerosing therapy (site-dependent) | 6 to 8 weeks | No response | | 4 | Second opinion with sports medicine or orthopedics | At any point from Step 2 onward | Ongoing limitation, imaging changes, or diagnostic uncertainty | | 5 | Surgical evaluation | After Step 3 failure or on structural imaging indication | Confirmed tear or refractory degenerative change |